BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. J Gastroenterol Hepatol 2019;34:186-93. [PMID: 29966173 DOI: 10.1111/jgh.14367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Xu C, Zheng T, Li Q, Yang S, Shao J, Guan W, Zhang S. A critical role of AMP-activated protein kinase in regulating intestinal nutrient absorption, barrier function, and intestinal diseases. J Cell Physiol 2022. [PMID: 35892164 DOI: 10.1002/jcp.30841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen M, Ruan G, Chen L, Ying S, Li G, Xu F, Xiao Z, Tian Y, Lv L, Ping Y, Cheng Y, Wei Y. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome. Front Endocrinol 2022;13:817100. [DOI: 10.3389/fendo.2022.817100] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Qian HY, Zhou F, Wu R, Cao XJ, Zhu T, Yuan HD, Chen YN, Zhang PA. Metformin Attenuates Bone Cancer Pain by Reducing TRPV1 and ASIC3 Expression. Front Pharmacol 2021;12:713944. [PMID: 34421611 DOI: 10.3389/fphar.2021.713944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med 2021;10:3429. [PMID: 34362210 DOI: 10.3390/jcm10153429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
6 Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome. Biomed Pharmacother 2021;139:111649. [PMID: 33957565 DOI: 10.1016/j.biopha.2021.111649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Okumura T, Nozu T, Ishioh M, Igarashi S, Kumei S, Ohhira M. Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats. J Pharmacol Sci 2021;146:183-91. [PMID: 34116731 DOI: 10.1016/j.jphs.2021.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Baeza-Flores GDC, Guzmán-Priego CG, Parra-Flores LI, Murbartián J, Torres-López JE, Granados-Soto V. Metformin: A Prospective Alternative for the Treatment of Chronic Pain. Front Pharmacol 2020;11:558474. [PMID: 33178015 DOI: 10.3389/fphar.2020.558474] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
9 Abboud C, Duveau A, Bouali-Benazzouz R, Massé K, Mattar J, Brochoire L, Fossat P, Boué-Grabot E, Hleihel W, Landry M. Animal models of pain: Diversity and benefits. J Neurosci Methods 2021;348:108997. [PMID: 33188801 DOI: 10.1016/j.jneumeth.2020.108997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
10 Ji Y, Hu B, Klontz C, Li J, Dessem D, Dorsey SG, Traub RJ. Peripheral mechanisms contribute to comorbid visceral hypersensitivity induced by preexisting orofacial pain and stress in female rats. Neurogastroenterol Motil 2020;32:e13833. [PMID: 32155308 DOI: 10.1111/nmo.13833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Bodnar RJ. Endogenous Opiates and Behavior: 2018. Peptides 2020;132:170348. [PMID: 32574695 DOI: 10.1016/j.peptides.2020.170348] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bahlouli W, Breton J, Lelouard M, L'Huillier C, Tirelle P, Salameh E, Amamou A, Atmani K, Goichon A, Bôle-Feysot C, Ducrotté P, Ribet D, Déchelotte P, Coëffier M. Stress-induced intestinal barrier dysfunction is exacerbated during diet-induced obesity. J Nutr Biochem 2020;81:108382. [PMID: 32417626 DOI: 10.1016/j.jnutbio.2020.108382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. Sci Rep 2019;9:19603. [PMID: 31862976 DOI: 10.1038/s41598-019-56132-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. European Journal of Pharmacology 2019;852:198-206. [DOI: 10.1016/j.ejphar.2019.03.037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]